Fast-disintegrating sublingual tablets: Efffect of epinephrine load on tablet characteristics

AAPS PharmSciTech

Volumn 7, Issue 2, 2006, Pages

  Rawas Qalaji, Mutasem M ^a   Simons, F Estelle R ^a   Simons, Keith J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anaphylaxis; Epinephrine; Fast disintegrating tablets; Sublingual; Transmucosal drug delivery

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; HYDROXYPROPYLCELLULOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE;

ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; EMERGENCY TREATMENT; FORCE; MEDICAL LITERATURE; SUBSTITUTION REACTION; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; UNITED STATES; WEIGHT;

EID: 33646540691     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070241     Document Type: Article

References (29)

1. Birudaraj R, Berner B, Shen S, Li X. Buccal permeation of buspirone: mechanistic studies on transport pathways. J Pharm Sci. 2005;94:70-78.
2. Ishikawa T, Koizumi N, Mukai B, et al. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules. Chem Pharm Bull (Tokyo). 2001;49:230-232.
3. Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol. Obstet Gynecol. 1997;89:340-345.
4. Joint Task Force on Practice Parameters; American Academy of Allergy Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115: S483-S523.
5. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol. 2003;3:313-318.
6. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. 2004;113:837-844.
7. Connors KA, Amidon GL, Stella VJ. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists. New York, NY. Wiley-Interscience Publications; 1986.
8. Simons KJ, Gu X, Simons FER. Sublingual epinephrine administration in humans: a preliminary study. J Allergy Clin Immunol. 2004; 113:S260.
9. Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol. 2006; 117:398-403.
10. Allen LV. Rapid-dissolve technology: an interview with Loyd V. Allen. Int J Pharm Technol. 2003;7:449-450.
11. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-making and clinical studies. Crit Rev Ther Drug Carrier Syst. 2004;21: 433-476.
12. Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull. 1995;18:1308-1310.
13. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo). 1996;44:2121-2127.
14. Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 1999;25:571-581.
15. Ishikawa T, Mukai B, Shiraishi S, et al. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method. Chem Pharm Bull (Tokyo). 2001;49:134-139.
16. Rawas-Qalaji MM, Simons FE, Simons KJ. Evaluation of the effect of changing tablet dimensions on the characteristics of fast-disintegrating sublingual epinephrine tablets for the first-aid treatment of anaphylaxis away from health care facilities. AAPS J. 2004;6:Abstract W4179.
17. USP/NF. Physical Tests: Uniformity of Dosage Units (905). 26/21 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 2003.
18. USP/NF. Physical Tests: Tablet Friability (1216). 26/21 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 2003.
19. Marshall K. Compression and consolidation of powdered solids. In: Lachman L, Lieberman HA, Kanig J, eds. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986: 66-99.
20. Sugimoto M, Matsubara K, Koida Y, Kobayashi M. The preparation of rapidly disintegrating tablets in the mouth. Pharm Dev Technol. 2001;6:487-493.
21. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15:295-305.
22. USP/NF. Physical Tests: Disintegration (701). 22/17 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 1990.
23. USP/NF. Official Monographs: Nitroglycerin Tablets. 22/17 ed. Rockville, MD: United States Pharmacopeial Convention Inc; 1990.
24. Diem K, Lentner C. Scientific Tables. Basle, Switzerland: Ciba-Geigy Limited; 1971.
25. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29-41.
26. el-Arini SK, Clas SD. Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer. Pharm Dev Technol. 2002;7:361-371.
27. Dor PJ, Fix JA. In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm Dev Technol. 2000;5:575-577.
28. Hedenus P, Stromme Mattsson M, Niklasson GA, Camber O, Ek R. Characterisation of instantaneous water absorption properties of pharmaceutical excipients. Int J Pharm. 2000;202:141-149.
29. Aly A, Semreen M, Qato M. Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharmaceutical Technology. 2005;January 2:68-78.